Comment from The Cure Coalition

Summary: The Cure Coalition, representing patients and health advocates, supports the FDA's efforts to modernize drug development and reduce animal testing while emphasizing that patient safety must remain the primary priority. They argue that the guidance should explicitly require rigorous validation of New Approach Methodologies (NAMs), distinguish between different types of animal models, and ensure that NAMs complement rather than replace validated safety testing, especially for vulnerable populations.